MC Insider Filing: Louise Mirrer Reports Multiple RSU Awards

Rhea-AI Filing Summary

Moelis & Co (MC) director Louise Mirrer reported receipt of restricted stock units (RSUs) on 09/18/2025. The Form 4 lists three non-derivative RSU entries: 1,253.3, 38.76, and 1,695.05 RSUs, each identified as dividend-equivalent RSUs that will vest concurrently with their underlying annual RSUs. The filing was executed by an attorney-in-fact and signed 09/19/2025. No option exercises or derivative transactions are reported. The Form 4 reflects additional equity compensation issued to a director rather than cash transactions or disposals.

Positive

• Equity alignment: RSUs issued to a director align management interests with shareholders by tying compensation to company stock
• Clear disclosure: Form 4 provides explicit counts and explains these are dividend-equivalent RSUs vesting with underlying annual RSUs

Negative

• None.

Insights

Financial Analyst

TL;DR: Director received multiple RSU grants totaling reported units, indicating equity compensation activity but no sales or purchases of shares.

The filing documents issuance of dividend-equivalent restricted stock units on 09/18/2025 in three line items (1,253.3; 38.76; 1,695.05 RSUs). These grants are non-derivative and vest with underlying annual RSUs per the explanations. For investors, this is a routine insider compensation disclosure showing alignment via equity rather than liquidity events; there are no reported disposals or option exercises that would directly affect share float from this filing alone.

Corporate Governance Expert

TL;DR: Routine director equity awards reported; documentation shows compliance with Section 16 reporting requirements.

The Form 4 identifies Louise Mirrer as a director and reports dividend-equivalent RSUs granted that vest alongside underlying annual RSUs. The explanations clarify the relationship to prior annual RSU grants and vesting schedules. The filing is signed by an attorney-in-fact, indicating procedural adherence. The disclosure is a governance-level compensation event rather than a change in control or related-party transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mirrer Louise

(Last) (First) (Middle)

399 PARK AVE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Moelis & Co [ MC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
2024 Annual Restricted Stock Units	09/18/2025		A		10.39	A	(1)(2)	1,253.3	D
2024 Annual Restricted Stock Units	09/18/2025		A		0.32	A	(1)(3)	38.76	D
2025 Annual Restricted Stock Units	09/18/2025		A		14.05	A	(1)(4)	1,695.05	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents the right to receive one share of Class A Common Stock.

2. 2024 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on September 24, 2024. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs.

3. 2024 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on May 1, 2025. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs.

4. 2025 Annual RSUs were issued as dividend equivalents on holder's underlying Annual RSUs issued on July 1, 2025. The dividend equivalent Annual RSUs will vest concurrently with the vesting of the underlying Annual RSUs.

	/s/ Osamu Watanabe as attorney-in-fact for Louise Mirrer	09/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Louise Mirrer report on the Form 4 for Moelis & Co (MC)?

The Form 4 reports receipt of non-derivative restricted stock units on 09/18/2025 in three entries totaling 1,253.3, 38.76, and 1,695.05 RSUs.

Are the reported RSUs immediately vested or restricted for MC director Louise Mirrer?

The filing states these are dividend-equivalent RSUs that will vest concurrently with their underlying annual RSUs, so they are not immediately vested.

Did Louise Mirrer sell or dispose of any Moelis & Co (MC) shares in this filing?

No. The Form 4 shows only acquisitions of RSUs (non-derivative grants) and no disposals or sales are reported.

When was the Form 4 signed and who signed it?

The Form 4 was signed by Osamu Watanabe as attorney-in-fact for Louise Mirrer on 09/19/2025.

What is the nature of the RSU entries reported on the Form 4?

Each RSU represents the right to receive one share of Class A common stock and are described as dividend equivalents tied to prior annual RSU grants.